Pharma Business Structure, M&As Evolving To Create Smaller Cross-Functional Units
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Strategies for mergers and acquisitions in the global pharmaceutical market are changing from marriages of equals to alliances and buyouts with biotechs, which often create cross-functional smaller units within big pharmas, said Hiroshi Nakamura, professor at the Keio University Business School